1. Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer 
Delmy Oliva, Mats Nilsson, Bengt-Åke Andersson, Lena Sharp, Freddi Lewin, Nongnit Laytragoon-Lewin 
Clinical and Translational Radiation Oncology 
Volume 2, Pages 1-6 (February 2017)
DOI: /j.ctro
Copyright © 2016 The Authors Terms and Conditions

2. Fig. 1
Inclusion process. FEC=5 Fluorouracil, Epirubicin and Cyclophosphamide, SNP=single nucleotide polymorphisms.
Clinical and Translational Radiation Oncology 2017 2, 1-6DOI: ( /j.ctro )
Copyright © 2016 The Authors Terms and Conditions

3. Fig. 2
(a) Reported total VAS-scores for nausea during the first 10days after start of chemotherapy. (b) Self-reported day for most intense side effects during the first 10days after start of chemotherapy.
Clinical and Translational Radiation Oncology 2017 2, 1-6DOI: ( /j.ctro )
Copyright © 2016 The Authors Terms and Conditions